|
|
|
 |
|
|
 |
 |
Inovio Biomedical Corporation
Company
Snapshot Purchase a Full Report on this Company
Business Description:
Inovio Biomedical Corporation. The Group's principal activity is to develop and commercializing novel medical therapies to cure diseases with critical unmet treatment needs using EPT. The Group's technology platform is based on medical devices that use Electroporation Therapy to deliver drugs and genes into cells. Its MedPulser Electroporation Therapy System is in Phase III clinical trials in the United States for the treatment of recurrent head and neck cancer. The Group currently conducting pre-marketing studies to support the commercialization of the MedPulserElectroporation Therapy System in Europe. The unique feature of the system, which uses a generator together with disposable needle applicators, is the preservation of healthy tissue at the margins of the tumor.
|
|
| |
Wright Quality Rating:
DCNN Rating Explanations |
| |
|
| |
|
| |
|
|
|
|
|
|
| |
| |
Stock Data: |
Recent Stock Performance: |
|
| |
Current Price (11/13/2009):
1.23
(Figures in
U.S. Dollars) |
|
1 Week |
-0.8% |
|
13 Weeks |
-16.3% |
|
|
|
|
|
|
|
|
|
4 Weeks |
-40.9% |
|
52 Weeks |
412.5% |
|
|
|
| |
| |
Inovio Biomedical Corporation
Key Data: |
|
|
|
| |
Ticker: |
INO |
Country: |
UNITED STATES |
| |
|
| |
Exchanges: |
ASE |
Major Industry: |
Drugs, Cosmetics & Health Care |
| |
|
| |
|
|
Sub Industry: |
Medical, Surgical & Dental Suppliers |
| |
|
| |
2008
Sales |
2,097,632
(Year Ending Jan 2009). |
Employees: |
27 |
| |
|
| |
Currency: |
U.S. Dollars |
Market Cap: |
125,617,837 |
| |
|
| |
Fiscal Yr Ends: |
December |
Shares Outstanding: |
102,128,323 |
| |
|
| |
Share Type: |
Common |
Closely Held Shares: |
471,544 |
|
| |
|
| |
| |
|
|
|
|
| |
Purchase a Full Subscription to All Reports From CorporateInformation: |
|
|
|
| |
The following reports, available for Inovio Biomedical Corporation, are typical of the content provided on all companies
covered in CorporateInformation.com
Basic Reports
Inovio Biomedical Corporation company Profile (Business Description, Price/Earnings, Price/Sales,
Price/Book, Dividend Yield, Company Officers, Contact Information), Competitor Analysis and up to ten-year history of Sales, Earnings per Share,
Dividends per Share, Security Price and Key Ratios. View Samples
Financial Statement Reports
Research reports that analyze Inovio Biomedical Corporation Income Statement and Balance Sheet along with
the Sources of Capital for a five-year period. View Samples
Financial Ratio Reports
Analyses reports that highlight Inovio Biomedical Corporation
Accounting Ratios, Asset Utilization, Fixed Charges Coverage, Liquidity, Leverage, Profitability,
Employee Efficiency and Per-Share Data over a five-year period. View Samples
Wright Quality Analyses Reports
Wright’s proprietary rating of corporate quality. The reports include a detailed
analysis of Inovio Biomedical Corporation Equity, Liquidity, Financial Strength,
Profitability and Corporate Growth. View Samples |
| |
|
|
| |
|
|
|
 |
|
|
|
|
|
|
|
CorporateInformation® website and selected data Copyright © 2000 -
by The Winthrop Corporation. All Rights Reserved. Except for quotations by established
news media, no pages on this site may be reproduced, stored in a retrieval system,
or transmitted for commercial purposes, in any form or by any means, electronic,
mechanical, photocopying, recording, or otherwise without prior written permission.
Information is believed reliable, but accuracy, completeness and opinions are not
guaranteed.
|
|
|
|